• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Heinrich Michael

    4/2/26 8:05:02 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ZSTK alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Heinrich Michael

    (Last)(First)(Middle)
    C/O ZEROSTACK CORP.
    40 KING STREET W., SUITE 2400

    (Street)
    TORONTOM5H 3Y2

    (City)(State)(Zip)

    ONTARIO, CANADA

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    ZeroStack Corp. [ ZSTK ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    XOfficer (give title below)Other (specify below)
    Executive Chairman
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    03/31/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Convertible Promissory Note$33.3403/31/2026J(1)4,902,22010/23/202509/22/2035Common Shares4,902,220(2)0IHeld by Zero Gravity Labs Inc., a corporation owned and controlled by the Reporting Person
    Explanation of Responses:
    1. On March 31, 2026, the Issuer entered into a note settlement agreement (the "Note Settlement Agreement") with Zero Gravity Labs Inc., a Delaware corporation ("0G") pursuant to which the convertible promissory note (the "Note") issued to 0G pursuant to the securities purchase agreement dated September 22, 2025, as amended on October 9, 2025, by and between the Issuer and 0G was settled. The Note Settlement Agreement provides that upon payment by the Issuer to 0G on or before March 31, 2026, of 50,000,000 Tokens (as defined in the Note), the Issuer shall be deemed to have paid the entire Principal (as defined in the Note) and Interest (as defined in the Note) of the Note in full and the Issuer shall have no further obligations under the Note and the Note shall be deemed to be satisfied.
    2. Represents issuance of convertible promissory note to Zero Gravity Labs Inc., a Delaware corporation owned and controlled by the Reporting Person, in the principal amount of 50,000,000 0G bitcoin tokens.
    /s/ Dany Vaiman as attorney-in-fact for Michael Heinrich04/02/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $ZSTK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ZSTK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZSTK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ZeroStack Announces Results of 2026 Annual and Special Meeting of Shareholders, Provides Phatebo Purchase Orders Update and Announces Closing of Previously Announced Cryptocurrency Financing

    Dallas, Texas--(Newsfile Corp. - July 20, 2026) - ZeroStack Corp. (NASDAQ:ZSTK) ("ZeroStack" or the "Company"), the first Nasdaq-listed, AI-focused asset management company, held its 2026 Annual and Special Meeting of Shareholders (the "Meeting"). The final voting results of the proposals submitted to a vote of the Company's shareholders at the Meeting are as follows: Proposal 1: Election of five directors to the board of directors of the Company (the "Board") to hold office until the Company's 2027 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified. If Proposal 7 is approved, the Board will be staggered as described in the proxy statement/pros

    7/20/26 4:01:00 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZeroStack Corp. Secures Purchase Orders for up to US$14.7 Million of Inventory from Two Pharmaceutical Companies

    Toronto, Ontario--(Newsfile Corp. - July 9, 2026) - ZeroStack Corp. (NASDAQ:ZSTK) (the "Company" or "ZeroStack"), the first Nasdaq-listed, AI-focused asset management company, today announced that it has secured pharmaceutical distribution purchase orders for up to approximately US$14.7 million (EUR 12.9 million) of inventory in Germany from two companies (the "Orders"). The Orders are expected to be fulfilled through the Company's wholly owned German subsidiary, Phatebo GmbH ("Phatebo").Phatebo has operated as a pharmaceutical distributor in Europe for more than then years and serves as the Company's primary operating subsidiary. In connection with ZeroStack's long-term strategy, Phatebo co

    7/9/26 8:01:00 AM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    DeFi Dev Corp. Announces Strategic Leadership Transition of DisclaimerCoin (DONT) to Dedicated Ecosystem Team

    BOCA RATON, FL, July 08, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (NASDAQ:DFDV) (the "Company"), the first U.S. public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced the strategic transition of leadership for DisclaimerCoin ("DONT"), the world’s first publicly traded company-created memecoin, to Daniel Reis-Faria, Chief Executive Officer of Nasdaq-listed ZeroStack Holdings Inc. (NASDAQ:ZSTK), and a dedicated team focused exclusively on growing the DisclaimerCoin ecosystem. The transition represents the next phase in DisclaimerCoin’s evolution. While DFDV pioneered the historic launch of DONT in January 2026, the Company believes th

    7/8/26 9:00:00 AM ET
    $DFDV
    $ZSTK
    Finance: Consumer Services
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ZSTK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman Heinrich Michael bought $3,479,013 worth of shares (4,608,575 units at $0.75) (SEC Form 4)

    4 - ZeroStack Corp. (0001790169) (Issuer)

    7/20/26 6:31:03 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ZSTK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman Heinrich Michael bought $3,479,013 worth of shares (4,608,575 units at $0.75) (SEC Form 4)

    4 - ZeroStack Corp. (0001790169) (Issuer)

    7/20/26 6:31:03 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Reis-Faria Daniel exercised 5,954,743 in-the-money shares at a strike of $0.00 (SEC Form 4)

    4 - ZeroStack Corp. (0001790169) (Issuer)

    7/20/26 6:26:15 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by CFO Vaiman Dany

    4 - ZeroStack Corp. (0001790169) (Issuer)

    7/20/26 6:21:25 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ZSTK
    SEC Filings

    View All

    ZeroStack Corp. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - ZeroStack Corp. (0001790169) (Filer)

    7/20/26 4:02:11 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by ZeroStack Corp.

    EFFECT - ZeroStack Corp. (0001790169) (Filer)

    6/18/26 12:15:34 AM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by ZeroStack Corp.

    424B3 - ZeroStack Corp. (0001790169) (Filer)

    6/17/26 4:53:30 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ZSTK
    Leadership Updates

    Live Leadership Updates

    View All

    DeFi Dev Corp. Announces Strategic Leadership Transition of DisclaimerCoin (DONT) to Dedicated Ecosystem Team

    BOCA RATON, FL, July 08, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (NASDAQ:DFDV) (the "Company"), the first U.S. public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced the strategic transition of leadership for DisclaimerCoin ("DONT"), the world’s first publicly traded company-created memecoin, to Daniel Reis-Faria, Chief Executive Officer of Nasdaq-listed ZeroStack Holdings Inc. (NASDAQ:ZSTK), and a dedicated team focused exclusively on growing the DisclaimerCoin ecosystem. The transition represents the next phase in DisclaimerCoin’s evolution. While DFDV pioneered the historic launch of DONT in January 2026, the Company believes th

    7/8/26 9:00:00 AM ET
    $DFDV
    $ZSTK
    Finance: Consumer Services
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care